Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome

NCT04447833 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

ARDS, Human
COVID

Interventions

DRUG: Mesenchymal Stromal Stem Cells - KI-MSC-PL-205

Sponsor

Uppsala University

Collaborators

[object Object]